4.18.2011

Hitachi Medical Systems America Announces FDA Clearance of its SCENARIA™ 64-Slice CT System

CLEVELAND--(BUSINESS WIRE)--Hitachi Medical Systems America, Inc., a leading provider of diagnostic imaging equipment, announced FDA clearance to market its SCENARIA CT system, the latest in the company’s line of CT products. SCENARIA combines the latest dose saving technologies in a new 64-slice platform that meets today’s need for a CT system that provides both routine and advanced applications with enhanced performance and value.

“SCENARIA includes a complete suite of dose reduction and awareness features, including Intelli IP™ Iterative Reconstruction, to enable high quality lower dose scanning across the full range of applications for Adult and Pediatric patients.”

“SCENARIA is another example of Hitachi’s ability to provide a superior product by combining the latest dose saving and imaging technologies with unparalleled ergonomic benefits afforded by a slimmer gantry design with wider 75cm aperture and a lateral shifting table,” said Mark Silverman, Manager of CT Marketing. “SCENARIA includes a complete suite of dose reduction and awareness features, including Intelli IP™ Iterative Reconstruction, to enable high quality lower dose scanning across the full range of applications for Adult and Pediatric patients.”

“With more than 68 Million CT procedures ordered across the US in 2009, it is important for CT to continue to achieve the good benefits of its diagnostic potential while further reducing patient radiation risk. SCENARIA, with its array of prescient technologies is an important tool for enhancing these benefits and reducing the radiation risk of CT Exams,” said Sheldon Schaffer, Vice President and General Manager, MR and CT.

source: Business Wire

4.06.2011

Philips to Take Orders for the Ingenia MRI System in the United States

ANDOVER, Mass., April 6, 2011 /PRNewswire/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the United States availability of the Ingenia MRI system, the first-ever digital broadband magnetic resonance imaging (MRI) solution. Previously available in Europe, Canada and Japan, the system has received 510(k) clearance from the U.S. Food and Drug Administration. Driven by Philips commitment to developing innovative patient care solutions, Ingenia MRI delivers exceptional image clarity, scanning efficiency and scalability designed to advance diagnosis and radiology workflow.

In order to visualize detailed structures within the human body, MRI orchestrates the application of radio frequency (RF), audio frequency and static magnetic fields, the strength of which is measured in Tesla (T) units. Clinicians have long relied on MRI for its exceptional ability to differentiate various soft tissues. Until now, all MRI systems have utilized analog components for the signal acquisition and processing needed to generate patient images. However, the use of analog components during these processes has limited the upper reaches of image clarity and quality.

The Ingenia system introduces, for the first time in MRI, digital signal acquisition and processing directly at the patient. By digitizing the signal directly in the RF receive coil nearest to the patient and transferring and processing the signal in digital form throughout the imaging chain, Ingenia is able to generate up to a 40 percent improvement in signal-to-noise ratio compared to previous generation systems*. This digital signal acquisition and processing facilitates the delivery of crisp image clarity to help clinicians make informed decisions for a wide range of clinical procedures, including traditional applications like neuro and musculoskeletal and fast-growing applications like body and cardiac.

source: PR Newswire